Cargando…
Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial
OBJECTIVE: One of the traditional aphrodisiacs used in various cultures is Crocus sativus, commonly called saffron. Previous studies have pointed to the possible applicability of saffron for sexual dysfunction in both men and women. This study investigates the effects of saffron capsules on female s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482709/ https://www.ncbi.nlm.nih.gov/pubmed/36186931 http://dx.doi.org/10.22038/AJP.2022.19714 |
_version_ | 1784791512985370624 |
---|---|
author | Kashani, Ladan Aslzadeh, Sahar Shokraee, Kamyar Shamabadi, Ahmad Tadayon Najafabadi, Borna Jafarinia, Morteza Esalatmanesh, Sophia Akhondzadeh, Shahin |
author_facet | Kashani, Ladan Aslzadeh, Sahar Shokraee, Kamyar Shamabadi, Ahmad Tadayon Najafabadi, Borna Jafarinia, Morteza Esalatmanesh, Sophia Akhondzadeh, Shahin |
author_sort | Kashani, Ladan |
collection | PubMed |
description | OBJECTIVE: One of the traditional aphrodisiacs used in various cultures is Crocus sativus, commonly called saffron. Previous studies have pointed to the possible applicability of saffron for sexual dysfunction in both men and women. This study investigates the effects of saffron capsules on female sexual dysfunction. MATERIALS AND METHODS: This study was a parallel-group, double-blind, randomized, placebo-controlled clinical trial. Participants, who were married women between 18 and 55 years of age suffering from severe sexual dysfunction, were randomized to receive either 15 mg Crocus sativus capsules twice daily or placebo. The treatment continued for 6 weeks, and patients were evaluated every 2 weeks. The primary outcome was the change in the female sexual function index score. Other outcomes included the female sexual function index sub-domains. RESULTS: Seventy -four patients were equally randomized to each group, and 34 in each group completed the trial. Participants in both groups experienced improved total scores at each visit. However, a repeated-measures ANOVA revealed that time treatment differed between groups in favor of the saffron group (p=0.050). During the 6(th )week follow-up, the saffron group had a 62% score improvement from baseline. Desire, lubrication, and satisfaction were female sexual function index domains in which saffron demonstrated superiority over placebo. The adverse event profile was similar for the groups, and no participant discontinued treatment. CONCLUSION: Findings of this study suggest that saffron might be a safe and effective option to ameliorate female sexual dysfunction. Further robust research is warranted. |
format | Online Article Text |
id | pubmed-9482709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mashhad University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-94827092022-09-29 Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial Kashani, Ladan Aslzadeh, Sahar Shokraee, Kamyar Shamabadi, Ahmad Tadayon Najafabadi, Borna Jafarinia, Morteza Esalatmanesh, Sophia Akhondzadeh, Shahin Avicenna J Phytomed Original Research Article OBJECTIVE: One of the traditional aphrodisiacs used in various cultures is Crocus sativus, commonly called saffron. Previous studies have pointed to the possible applicability of saffron for sexual dysfunction in both men and women. This study investigates the effects of saffron capsules on female sexual dysfunction. MATERIALS AND METHODS: This study was a parallel-group, double-blind, randomized, placebo-controlled clinical trial. Participants, who were married women between 18 and 55 years of age suffering from severe sexual dysfunction, were randomized to receive either 15 mg Crocus sativus capsules twice daily or placebo. The treatment continued for 6 weeks, and patients were evaluated every 2 weeks. The primary outcome was the change in the female sexual function index score. Other outcomes included the female sexual function index sub-domains. RESULTS: Seventy -four patients were equally randomized to each group, and 34 in each group completed the trial. Participants in both groups experienced improved total scores at each visit. However, a repeated-measures ANOVA revealed that time treatment differed between groups in favor of the saffron group (p=0.050). During the 6(th )week follow-up, the saffron group had a 62% score improvement from baseline. Desire, lubrication, and satisfaction were female sexual function index domains in which saffron demonstrated superiority over placebo. The adverse event profile was similar for the groups, and no participant discontinued treatment. CONCLUSION: Findings of this study suggest that saffron might be a safe and effective option to ameliorate female sexual dysfunction. Further robust research is warranted. Mashhad University of Medical Sciences 2022 /pmc/articles/PMC9482709/ /pubmed/36186931 http://dx.doi.org/10.22038/AJP.2022.19714 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Kashani, Ladan Aslzadeh, Sahar Shokraee, Kamyar Shamabadi, Ahmad Tadayon Najafabadi, Borna Jafarinia, Morteza Esalatmanesh, Sophia Akhondzadeh, Shahin Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial |
title |
Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial |
title_full |
Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial |
title_fullStr |
Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial |
title_full_unstemmed |
Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial |
title_short |
Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial |
title_sort | crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482709/ https://www.ncbi.nlm.nih.gov/pubmed/36186931 http://dx.doi.org/10.22038/AJP.2022.19714 |
work_keys_str_mv | AT kashaniladan crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial AT aslzadehsahar crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial AT shokraeekamyar crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial AT shamabadiahmad crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial AT tadayonnajafabadiborna crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial AT jafariniamorteza crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial AT esalatmaneshsophia crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial AT akhondzadehshahin crocussativussaffroninthetreatmentoffemalesexualdysfunctionathreecenterdoubleblindrandomizedandplacebocontrolledclinicaltrial |